Ledderhose’s Disease, also known as plantar fibromatosis, is a rare, non-malignant disorder characterized by the gradual growth of fibrous nodules along the plantar fascia of the foot. These nodules can cause discomfort, pain, and functional disability, significantly affecting a person’s quality of life. The disease is often associated with other fibromatoses, such as Dupuytren’s contracture and Peyronie’s disease.
Overview and History
The first documented cases of Ledderhose’s Disease were reported by Plater in 1610 and later by Madelung in 1875. However, it is Dr. George Ledderhose, a German physician, who is most commonly associated with the condition, having detailed the disease in greater depth in 1894. The disease belongs to a family of fibromatoses, disorders involving the proliferation of collagen and fibroblasts, which also include Dupuytren’s contracture (affecting the hand) and Peyronie’s disease (affecting the penis). Though benign, the disease can cause significant discomfort, and it is not typically linked to malignant transformation .
Anatomy and Biomechanics of the Plantar Fascia
The plantar fascia is a thick fibrous band that originates from the calcaneus and extends to the toes. It plays a vital role in supporting the longitudinal arch of the foot. The central part of the plantar fascia, in particular, is often affected in Ledderhose’s Disease. During activities such as walking, the fascia tightens, helping to maintain the arch. In cases of plantar fibromatosis, the disease can disrupt the fascia, leading to pain and functional limitations .
Pathophysiology
From a histological perspective, the nodules in Ledderhose’s Disease are composed of dense fibrocellular tissue, with a parallel arrangement of fibrocytes and fibrillar collagen. The disease progresses through three phases:
- Proliferative Phase: Characterized by minimal collagen and an abundance of fibroblasts.
- Active Phase: Features increased collagen and more mature fibroblasts.
- Maturation Phase: In this phase, collagen fibers form larger bundles, but there is no mitotic activity or abnormal cells .
Clinical Presentation
The condition typically manifests as slow-growing nodules in the medial central part of the plantar fascia, with some cases extending up to 10.5 cm in size. Initially, the nodules are often painless but can become painful as they press on nearby nerves, muscles, or tendons. While the majority of cases do not cause toe contractures, as seen in Dupuytren’s contracture, severe cases of fibromatosis may lead to such deformities. The disease commonly affects both feet, with about 25% of cases presenting bilaterally .
Imaging and Diagnosis
The most effective and commonly used imaging methods for diagnosing Ledderhose’s Disease include ultrasound and MRI. Ultrasound offers a quick and non-invasive way to confirm the diagnosis, showing nodules as hypoechoic lesions with a heterogeneous internal structure. MRI, especially with contrast, provides a more detailed view, particularly in more advanced or aggressive cases. MRI can help assess the depth of tissue involvement and is useful for detecting small, difficult-to-visualize nodules .
Treatment Options
Several treatment options are available for managing Ledderhose’s Disease. These range from conservative methods to surgical intervention, depending on the severity of the condition and the patient’s symptoms.
Conservative Management
- Steroid Injections: Often the first line of treatment, these help reduce nodule size and alleviate pain. However, recurrence is common, and multiple rounds of injections may be required .
- Verapamil: A calcium channel blocker, has been shown to reduce nodule size by inhibiting collagen production .
- Extracorporeal Shock Wave Therapy (ESWT): ESWT has been found to relieve pain and soften nodules, although it does not reduce nodule size significantly .
- Radiotherapy: This has been used with varying success to shrink nodules, especially in early-stage disease, though the risk of skin dryness and other side effects must be considered.
Surgical Management
When conservative treatments fail, surgery may be considered. Surgical options include local excision, wide excision, and complete fasciectomy. Recurrence rates are high, particularly with less extensive excisions, and complications such as nerve damage, painful scarring, and loss of arch height can occur. Endoscopic subtotal fasciectomy, a less invasive approach, has shown promise in reducing recurrence and minimizing surgical complications.
Prognosis
While Ledderhose’s Disease is benign, it often presents a challenge due to its tendency to recur after treatment, particularly surgery. The recurrence rate can be as high as 60%, and in cases with bilateral involvement or multiple nodules, recurrence is even more likely. Long-term management often involves repeated conservative treatments and careful monitoring of symptoms .
Conclusion
Ledderhose’s Disease remains a rare but impactful disorder, primarily affecting middle-aged men and presenting with the gradual formation of painful nodules along the plantar fascia. While conservative management strategies such as steroid injections, shock wave therapy, and radiotherapy are commonly used, surgery may be required for more severe or recurrent cases.
Do you have more questions?
Q. What is Ledderhose’s disease?
A. Ledderhose’s disease is a rare condition characterized by the development of firm nodules on the plantar fascia of the foot, often causing pain and difficulty walking.
Q. What causes Ledderhose’s disease?
A. The exact cause is unknown, but it is associated with conditions like Dupuytren’s contracture, Peyronie’s disease, diabetes, and epilepsy, and may have a genetic component.
Q. Who is more likely to develop Ledderhose’s disease?
A. It is more commonly seen in middle-aged and older adults, and there may be a higher incidence in men.
Q. What are the symptoms of Ledderhose’s disease?
A. Symptoms include firm, slow-growing nodules in the arch of the foot, pain when walking or standing, and sometimes contractures of the toes.
Q. How is Ledderhose’s disease diagnosed?
A. Diagnosis is primarily clinical, based on physical examination, but imaging like ultrasound or MRI can help confirm the presence and extent of the nodules.
Q. What non-surgical treatments are available for Ledderhose’s disease?
A. Non-surgical options include orthotics, physical therapy, steroid injections, radiation therapy, and shock wave therapy.
Q. When is surgery considered for Ledderhose’s disease?
A. Surgery is considered when conservative treatments fail and the pain or deformity interferes significantly with daily activities.
Q. What does surgery for Ledderhose’s disease involve?
A. Surgery typically involves removal of the affected part of the plantar fascia, which may require careful post-operative rehabilitation.
Q. What is the recovery like after surgery for Ledderhose’s disease?
A. Recovery may involve several weeks of limited weight-bearing and physical therapy to regain function and reduce recurrence risk.
Q. Can Ledderhose’s disease come back after treatment?
A. Yes, there is a risk of recurrence even after surgery, particularly if the underlying contributing factors are still present.
Q. Is Ledderhose’s disease cancerous?
A. No, Ledderhose’s disease is benign and not cancerous, although the nodules can be painful and disabling.
Dr. Mo Athar
